SEC Form 4 · accession 0001055726-16-000064
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Niranjan Sardesai
Officer — Chief Operating Officer
Period of report
Aug 28, 2016
Accepted (ET)
Aug 30, 2016 · 4:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 28, 2016 | M | 33,116 | $6.12 | A | 70,234 | D | |
| Common Stock | Aug 29, 2016 | S | 21,800 | $9.2997 | D | 48,434 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Options | $6.12 | Aug 28, 2016 | M | 33,116 | D | Aug 28, 2009 | Aug 28, 2016 | Common Stock | 33,116 | 0 | D |